Effectiveness of Orthokeratology in Myopia Control

计划入组 45 人 · 首次发布于 2018 年 3 月 14 日

Myopia Control With Orthokeratology Contact Lenses in Spain

计划入组 69 人 · 首次发布于 2021 年 3 月 19 日

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

计划入组 112 人 · 首次发布于 2024 年 10 月 31 日

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

DPP-IV inhibitors (Chinese Academy of Sciences/Zhejiang University)

PIBC

AMERICAN ACADEMY OF OPHTHALMOLOGY

United States

American Academy Of Pediatrics

United States

AMERICAN ACADEMY OF FAMILY PHYSICIANS

United States

FDA Rejection of Low-Dose Atropine Sparks Industry Petition and Calls for Myopia Reclassification

AAO 2024: 3D-Printed Glasses, ANX007 for Geographic Atrophy, and Cataract Surgery Risks Highlighted

REGENXBIO Presents ABBV-RGX-314 Data for Wet AMD and Diabetic Retinopathy at AAO 2024